Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC9 | O60706 | 11/20 | 0.57 |
| ▸ | KCNJ11 | Q14654 | 11/20 | 0.57 |
| ▸ | ABCC8 | Q09428 | 9/20 | 0.57 |
| ▸ | KCNJ8 | Q15842 | 9/20 | 0.57 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7017810 | 0.89 | ABCC9 (0.53) | ABCC9KCNJ11ABCC8KCNJ8TSHR | |
| SCHEMBL7099478 | 0.83 | ABCC9 (0.41) | ABCC9KCNJ11ABCC8KCNJ8TSHR | |
| SCHEMBL10790585 | 0.80 | ADORA3 (0.55) | TSHRKDM4EALDH1A1GAAPOLB | |
| SCHEMBL7099447 | 0.80 | ABCC9 (0.55) | ABCC9KCNJ11ABCC8KCNJ8TSHR | |
| SCHEMBL7104751 | 0.79 | ABCC9 (0.57) | ABCC9KCNJ11ABCC8KCNJ8 | |
| SCHEMBL10784036 | 0.79 | CYP2C9 (0.44) | TSHRLMNANPSR1KDM4EALDH1A1 | |
| SCHEMBL10785934 | 0.79 | NR1I2 (0.46) | TSHRLMNAKDM4EALDH1A1GAA | |
| SCHEMBL7014633 | 0.79 | ABCC9 (0.52) | ABCC9KCNJ11ABCC8KCNJ8TSHR | |
| SCHEMBL10789678 | 0.76 | ALOX15 (0.50) | TSHRLMNANPSR1KDM4EALDH1A1 | |
| SCHEMBL6925767 | 0.76 | ABCC9 (0.66) | ABCC9KCNJ11ABCC8KCNJ8TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020099070-A1 | Dihydronaphthyridine potassium channel openers | ABBOTT LABORATORIES | 2002-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099070-A1 | Dihydronaphthyridine potassium channel openers | KCNH1, KCNN1, KCNJ2 | ABCC9 440/4885KCNJ11 8/4885ABCC8 645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.